Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|97|1|19-25

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.97, Iss.1, 2012-03, pp. : 19-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-01 ,pp. : 74-85

Karger

Access to resources Recommend Favorite

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-10 ,pp. : 261-271

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 186-194

Karger

Access to resources Recommend Favorite

Combination of Cross-Sectional and Molecular Imaging Studies in the Localization of Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 99, Iss. 2, 2014-01 ,pp. : 63-74

Karger

Access to resources Recommend Favorite

When to Look for Von Hippel-Lindau Disease in Gastroenteropancreatic Neuroendocrine Tumors?

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 39-46

Karger

Access to resources Recommend Favorite